Categories: News

RMS Medical Products to Present at the 29th Annual Oppenheimer Healthcare Conference

CHESTER, NY / ACCESSWIRE / March 15, 2019 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced that Dan Goldberger, Executive Chairman, will be presenting at the 29th Annual Oppenheimer Healthcare Conference in New York, NY on Tuesday, March 19th.

Slides from management’s presentation will be available on the Company website, www.rmsmedicalproducts.com, and remain available for a period of at least 90 days following the presentation.

About RMS Medical Products

RMS develops, manufactures and commercializes medical products used for home infusions. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, RMS Precision Flow Rate Tubing and RMS HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in professional healthcare settings as well as at home. For more information about RMS Medical, please visit www.rmsmedicalproducts.com.

Contact

CG Capital
Rich Cockrell
877.889.1972
investorrelations@cg.capital
www.cg.capital

SOURCE: Repro Med Systems, Inc.

View source version on accesswire.com:
https://www.accesswire.com/539135/RMS-Medical-Products-to-Present-at-the-29th-Annual-Oppenheimer-Healthcare-Conference

user

Recent Posts

DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Ascension Health Customers Whose Data May Have Been Compromised

NEWTOWN, Pa., Dec. 22, 2024 /PRNewswire/ -- The law firm of Edelson Lechtzin LLP is…

17 minutes ago

Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle

Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…

1 day ago

WillowWood Rebrand by DD.NYC Wins Gold Anthem Award for Product and Innovation in 2024 Rebrand

MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…

2 days ago

Quantum Biopharma Announces Closing of Second Tranche

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…

2 days ago

Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

2 days ago